Keywords: SSRI, Major Depressive Disorder, CNN, Mental Depression, Machine Learning
Abstract: Major Depressive Disorder (MDD) is a leading cause of disability worldwide, yet selective serotonin reuptake inhibitors (SSRIs) yield highly variable outcomes across patients. To address the need for individualized treatment prediction, we introduce NeuroPredict, a non‑invasive EEG‑based framework that leverages rich time–frequency representations of pre‑treatment signals. EEG data were rigorously preprocessed with artifact removal and transformed using Wigner-Ville distribution (WVD), continuous wavelet transform (CWT), and constant‑Q transform (CQT), then classified with a tailored convolutional neural network (CNN). We systematically benchmarked NeuroPredict against state‑of‑the‑art pretrained models (Xception, DenseNet201, MobileNetV2) and EEG‑specific baselines (EEGNet, SleepEEGNet, DeepConvNet). Our proposed CNN consistently outperformed these approaches, achieving a peak accuracy of 98.28% and ROC of 98.20%, alongside strong precision, recall, and F1 score. Beyond predictive gains, we also highlight how large language model (LLM)-based support can enhance interpretability and streamline the analytic pipeline. These findings establish NeuroPredict as a scalable and clinically viable tool for precision prediction of SSRI treatment response, advancing the integration of data‑driven methods into personalized psychiatry.
Primary Subject Area: Transfer Learning and Domain Adaptation
Secondary Subject Area: Application: Neuroimaging
Registration Requirement: Yes
Reproducibility: https://github.com/fahimulkabir/NeuroPredict
Visa & Travel: Yes
Read CFP & Author Instructions: Yes
Originality Policy: Yes
Single-blind & Not Under Review Elsewhere: Yes
LLM Policy: Yes
Submission Number: 260
Loading